A draft report from the Institute for Clinical and Economic Review, known as ICER, found that there is insufficient evidence…
Articles by Marisa Wexler, MS
LX1001, a gene therapy for Alzheimer’s disease being developed by Lexeo Therapeutics, has been granted fast track designation…
A new Phase 3 clinical trial, called EMBARK, will evaluate the long-term safety and efficacy of aducanumab (BIIB037), an investigational…
Despite minor improvements in recent years, the availability of care for people with dementia in Europe is largely inadequate, according…
People with mild-to-moderate Alzheimer’s disease treated for three weeks with sargramostim, a medication that activates the immune system,…
Cassava Sciences plans to launch two Phase 3 clinical trials evaluating the efficacy of simufilam, its investigational…
Simufilam, an investigational oral medication being developed by Cassava Sciences, improved cognition and behavior in people with Alzheimer’s…
People with Alzheimer’s disease, as well as their caregivers, are being urged — on social media and via press releases…
A newly developed technique could make it easier to measure very small concentrations of molecules, which may have implications in…
The last participant has completed the planned 24 weeks in the Phase 2 PEGASUS clinical trial, which is assessing the…